PNC Financial Services Group
ANRO icon

PNC Financial Services Group’s Alto Neuroscience ANRO Stock Holding History

PNC Financial Services Group’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.1K Sell
1,206
-101
-8% -$1.87K ﹤0.01% 3551
2025
Q4 		$23.3K Sell
1,307
-159
-11% -$2K ﹤0.01% 3597
2025
Q3 		$5.89K Sell
1,466
-297
-17% -$985 ﹤0.01% 4141
2025
Q2 		$3.88K Buy
1,763
+1,621
+1,142% +$3.86K ﹤0.01% 4222
2025
Q1 		$306 Buy
+142
New +$508 ﹤0.01% 4724

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PNC Financial Services Group's ANRO Position: Q1 2026 in Review

PNC Financial Services Group reduced its Alto Neuroscience (ANRO) stake by 7.7% in Q1 2026, selling an estimated $1.87K and leaving 1,206 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3551.

PNC Financial Services Group first reported a position in ANRO in Q1 2025 and has held it in 5 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • PNC Financial Services Group held 1,206 shares of Alto Neuroscience worth $27.1K as of Q1 2026.
  • PNC Financial Services Group sold 101 Alto Neuroscience shares in Q1 2026, an estimated $1.87K.
  • Alto Neuroscience made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3551 holding.
  • PNC Financial Services Group first reported a position in Alto Neuroscience in Q1 2025 and has held it in 5 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.